| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
|
Mejia Saldarriaga, Mateo
|
|
|
8 |
15 |
p. 3859-3869
|
artikel
|
| 2 |
Affimer reagents as tool molecules to modulate platelet GPVI-ligand interactions and specifically bind GPVI dimer
|
Xu, Rui-Gang
|
|
|
8 |
15 |
p. 3917-3928
|
artikel
|
| 3 |
A JAGN1-associated severe congenital neutropenia zebrafish model revealed an altered G-CSFR signaling and UPR activation
|
Doll, Larissa
|
|
|
8 |
15 |
p. 4050-4065
|
artikel
|
| 4 |
AMPK drives both glycolytic and oxidative metabolism in murine and human T cells during graft-versus-host disease
|
Ramgopal, Archana
|
|
|
8 |
15 |
p. 4149-4162
|
artikel
|
| 5 |
Analysis of polyfunctionality for enhanced BAFF-R CAR T-cell therapy for hematologic malignancies
|
Dong, Zhengyuan
|
|
|
8 |
15 |
p. 4066-4076
|
artikel
|
| 6 |
A simplified G-CSF–free procedure allows for in vivo HSC gene therapy of sickle cell disease in a mouse model
|
Li, Chang
|
|
|
8 |
15 |
p. 4089-4101
|
artikel
|
| 7 |
Cardiovascular and genetic determinants of platelet high responsiveness: results from the Gutenberg Health Study
|
Baidildinova, Gaukhar
|
|
|
8 |
15 |
p. 3870-3874
|
artikel
|
| 8 |
CG001, a C3b-targeted complement inhibitor, blocks 3 complement pathways: development and preclinical evaluation
|
Li, Ling
|
|
|
8 |
15 |
p. 4181-4193
|
artikel
|
| 9 |
Characterization of cases with the rare cytogenetic abnormality i(7)(p10) reveals an association with IDH2-mutated AML
|
Stengel, Anna
|
|
|
8 |
15 |
p. 4125-4128
|
artikel
|
| 10 |
Chronic TNF in the aging microenvironment exacerbates Tet2 loss-of-function myeloid expansion
|
Quin, Candice
|
|
|
8 |
15 |
p. 4169-4180
|
artikel
|
| 11 |
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma
|
Kfir-Erenfeld, Shlomit
|
|
|
8 |
15 |
p. 4077-4088
|
artikel
|
| 12 |
CRISPR/Cas9-mediated gene disruption determines the roles of MITF and CITED2 in human mast cell differentiation
|
Mo, Jiezhen
|
|
|
8 |
15 |
p. 3941-3945
|
artikel
|
| 13 |
Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry
|
Schonfeld, Sara J.
|
|
|
8 |
15 |
p. 4102-4112
|
artikel
|
| 14 |
Deep PIM kinase substrate profiling reveals new rational cotherapeutic strategies for acute myeloid leukemia
|
Joglekar, Tejashree
|
|
|
8 |
15 |
p. 3880-3892
|
artikel
|
| 15 |
Deletion of pyruvate dehydrogenase kinases reduces susceptibility to deep vein thrombosis in mice
|
Flora, Gagan D.
|
|
|
8 |
15 |
p. 3906-3913
|
artikel
|
| 16 |
Determinants of cognitive dysfunction in adults with sickle cell–related stroke or suspected neurological morbidity
|
Messimeris, Despina
|
|
|
8 |
15 |
p. 3993-4002
|
artikel
|
| 17 |
Donor safety confirmed
|
Szer, Jeff
|
|
|
8 |
15 |
p. 4194-4195
|
artikel
|
| 18 |
Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome
|
DiNardo, Courtney D.
|
|
|
8 |
15 |
p. 4209-4220
|
artikel
|
| 19 |
Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death
|
Yao, Yao
|
|
|
8 |
15 |
p. 4003-4016
|
artikel
|
| 20 |
Haploidentical transplantation in primary refractory/relapsed secondary vs de novo AML: from the ALWP/EBMT
|
Nagler, Arnon
|
|
|
8 |
15 |
p. 4223-4233
|
artikel
|
| 21 |
Hason M, Mikulasova T, Machonova O, et al. M-CSFR/CSF1R signaling regulates myeloid fates in zebrafish via distinct action of its receptors and ligands. Blood Adv. 2022;6(5)1474-1488.
|
|
|
|
8 |
15 |
p. 4163
|
artikel
|
| 22 |
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis
|
Lazzaroni, Francesca
|
|
|
8 |
15 |
p. 3972-3984
|
artikel
|
| 23 |
Long-term outcomes of peripheral blood stem cell unrelated donors mobilized with filgrastim
|
Stefanski, Heather E.
|
|
|
8 |
15 |
p. 4196-4206
|
artikel
|
| 24 |
Mitoxantrone ameliorates ineffective erythropoiesis in a β-thalassemia intermedia mouse model
|
Zhang, Haihang
|
|
|
8 |
15 |
p. 4017-4024
|
artikel
|
| 25 |
Modified Delphi panel consensus recommendations for management of severe aplastic anemia
|
Babushok, Daria V.
|
|
|
8 |
15 |
p. 3946-3960
|
artikel
|
| 26 |
Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B
|
Gao, Meng
|
|
|
8 |
15 |
p. 3893-3905
|
artikel
|
| 27 |
Need for consensus on primary end points and efficacy definitions in trials for adult acute lymphoblastic leukemia
|
Wieduwilt, Matthew J.
|
|
|
8 |
15 |
p. 4234-4238
|
artikel
|
| 28 |
Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma
|
Ramirez, Cody A.
|
|
|
8 |
15 |
p. 4035-4049
|
artikel
|
| 29 |
Neurobeachin regulates hematopoietic progenitor differentiation and survival by modulating Notch activity
|
Ganuza, Miguel
|
|
|
8 |
15 |
p. 4129-4143
|
artikel
|
| 30 |
PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT
|
Montoro, Juan
|
|
|
8 |
15 |
p. 3985-3992
|
artikel
|
| 31 |
Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas
|
Bender, Jonathan D.
|
|
|
8 |
15 |
p. 4164-4168
|
artikel
|
| 32 |
Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19
|
Grosso, Dolores
|
|
|
8 |
15 |
p. 4113-4124
|
artikel
|
| 33 |
Second chances for secondary AML
|
Appelbaum, Jacob S.
|
|
|
8 |
15 |
p. 4221-4222
|
artikel
|
| 34 |
Targeting CD38 with isatuximab and a novel CD38/CD3×CD28 trispecific T-cell engager in older patients with acute myeloid leukemia
|
Martín-Sánchez, Esperanza
|
|
|
8 |
15 |
p. 3875-3879
|
artikel
|
| 35 |
T-cell malignancies with anti-CD19 chimeric antigen receptor T-cell therapy
|
Martin, Lisa J.
|
|
|
8 |
15 |
p. 4144-4148
|
artikel
|
| 36 |
The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential
|
Nakajima, Yuto
|
|
|
8 |
15 |
p. 3929-3940
|
artikel
|
| 37 |
The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts
|
Choi, In Young
|
|
|
8 |
15 |
p. 3961-3971
|
artikel
|
| 38 |
This differentiation block will not stand, man: ivosidenib for MDS
|
Beechinor, Ryan J.
|
|
|
8 |
15 |
p. 4207-4208
|
artikel
|
| 39 |
Thrombophilia management calculator
|
Hozo, Iztok
|
|
|
8 |
15 |
p. 3914-3916
|
artikel
|
| 40 |
Venetoclax resistance leads to broad resistance to standard-of-care anti-MM agents, but not to immunotherapies
|
Deng, Shuhui
|
|
|
8 |
15 |
p. 4025-4034
|
artikel
|
Tijdschrift beschrijving